Wei Wang
Impact in
- Biomaterials top 0.2%
- Nanoparticle-Based Drug Delivery
- Drug Discovery top 1%
Papers in
- Biomaterials 46
- Nanoparticle-Based Drug Delivery 46
-
- Traditional Chinese Medicine Analysis 16
- Co-authors
- Lu Tang (31 shared papers)Yijun Mei (18 shared papers)Yue Yin (16 shared papers)Zhi Yuan (10 shared papers)Chuangnian Zhang (9 shared papers)Jianping Zhou (13 shared papers)Qiaqia Xiao (15 shared papers)Yujie Su (12 shared papers)
- Journals
- Biomaterials (8 papers)Journal of Biological Chemistry (7 papers)ACS Applied Materials & Interfaces (6 papers)Pharmaceutics (6 papers)Frontiers in Endocrinology (5 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Wei Wang
315 papers receiving 10k citations
Wei Wang's Hit Papers
Peers
Comparison fields: 5 of 143
- Biomaterials 2k
- Drug Discovery 35
- Pharmaceutical Science 574
- Complementary and alternative medicine 585
- Pharmacology 744
Countries citing papers authored by Wei Wang
This map shows the geographic impact of Wei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Wang more than expected).
Fields of papers citing papers by Wei Wang
This network shows the impact of papers produced by Wei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Wang. The network helps show where Wei Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 323 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Scutellaria baicalensis Georgi polysaccharide ameliorates DSS-induced ulcerative colitis by improving intestinal barrier function and modulating gut microbiota Hit paper breakdown → | 2020 | 397 |
| 2 | Allogeneic Periodontal Ligament Stem Cell Therapy for Periodontitis in Swine Hit paper breakdown → | 2010 | 335 |
| 3 | 2011 | 253 | |
| 4 | 2010 | 218 | |
| 5 | 2015 | 202 | |
| 6 | 2014 | 185 | |
| 7 | 2016 | 162 | |
| 8 | 2021 | 146 | |
| 9 | 2009 | 145 | |
| 10 | 2023 | 137 | |
| 11 | 2023 | 133 | |
| 12 | 2022 | 124 | |
| 13 | 2008 | 121 | |
| 14 | 2012 | 119 | |
| 15 | 2010 | 114 | |
| 16 | 2021 | 110 | |
| 17 | 2006 | 107 | |
| 18 | 2016 | 106 | |
| 19 | 2014 | 105 | |
| 20 | 2003 | 102 |
About Wei Wang
Wei Wang is a scholar working on Biomaterials, Complementary and alternative medicine, Molecular Biology, Pharmaceutical Science and Pharmacology, having authored 323 papers that have together received 10.2k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (46 papers), Nanoplatforms for cancer theranostics (33 papers), RNA Interference and Gene Delivery (31 papers), Traditional Chinese Medicine Analysis (16 papers), Flavonoids in Medical Research (12 papers), Advanced Drug Delivery Systems (10 papers), Receptor Mechanisms and Signaling (9 papers) and Advancements in Transdermal Drug Delivery (9 papers). The work is most often cited by research in Biomaterials (2k citations), Drug Discovery (35 citations), Pharmaceutical Science (574 citations), Complementary and alternative medicine (585 citations) and Pharmacology (744 citations). Wei Wang has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Lu Tang, Yijun Mei, Yue Yin, Zhi Yuan, Chuangnian Zhang, Jianping Zhou, Qiaqia Xiao, Yujie Su, Yuqi Cao and Xiuhua Wang. Their work appears in journals such as Biomaterials, Journal of Biological Chemistry, ACS Applied Materials & Interfaces, Pharmaceutics and Frontiers in Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.